

Mounjaro hits India, Bengal's Diamond Harbour Model, and Waqf Bill faces heat
Apr 3, 2025
A groundbreaking weight loss drug, Mounjaro, is making waves in India, promising innovative benefits compared to competitors. The podcast dives into the political landscape in West Bengal, spotlighting the Diamond Harbour Model and its influence on local governance. Listeners will also hear about the fiery debates surrounding the Waqf Amendment Bill, grappling with issues like minority representation and government oversight. These topics weave together health, politics, and societal concerns, keeping listeners engaged and informed.
AI Snips
Chapters
Transcript
Episode notes
How Monjaro Works
- Monjaro and similar weight-loss drugs work by mimicking gut hormones, impacting insulin and glucagon secretion, and slowing digestion.
- These drugs also affect brain reward pathways, reducing cravings for unhealthy foods and potentially other addictions.
From Diabetes Drug to Obesity Treatment
- Initially developed for diabetes, drugs like Monjaro showed significant weight loss, leading to their use in obesity treatment.
- Similar to bariatric surgery, these drugs improve symptoms of obesity-related conditions like diabetes, hypertension, and sleep apnea.
Monjaro's Weight Loss Effects
- Monjaro can reduce up to 25% of body weight in 72 weeks, comparable to bariatric surgery.
- Stopping the drug can lead to weight regain, though not necessarily to the original weight.